Avricore Health Inc.
Avricore Health Inc. Fundamental Analysis
Avricore Health Inc. (AVCRF) shows moderate financial fundamentals with a PE ratio of -4.02, profit margin of -84.76%, and ROE of -95.30%. The company generates $0.0B in annual revenue with strong year-over-year growth of 37.32%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -108.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze AVCRF's fundamental strength across five key dimensions:
Efficiency Score
WeakAVCRF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentAVCRF trades at attractive valuation levels.
Growth Score
ModerateAVCRF shows steady but slowing expansion.
Financial Health Score
ExcellentAVCRF maintains a strong and stable balance sheet.
Profitability Score
WeakAVCRF struggles to sustain strong margins.
Key Financial Metrics
Is AVCRF Expensive or Cheap?
P/E Ratio
AVCRF trades at -4.02 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, AVCRF's PEG of 0.20 indicates potential undervaluation.
Price to Book
The market values Avricore Health Inc. at 5.05 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -11.92 times EBITDA. This is generally considered low.
How Well Does AVCRF Make Money?
Net Profit Margin
For every $100 in sales, Avricore Health Inc. keeps $-84.76 as profit after all expenses.
Operating Margin
Core operations generate -43.83 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-95.30 in profit for every $100 of shareholder equity.
ROA
Avricore Health Inc. generates $-1.22 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Avricore Health Inc. generates limited operating cash flow of $-147.14K, signaling weaker underlying cash strength.
Free Cash Flow
Avricore Health Inc. generates weak or negative free cash flow of $-263.49K, restricting financial flexibility.
FCF Per Share
Each share generates $-0.00 in free cash annually.
FCF Yield
AVCRF converts -4.03% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-4.02
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.20
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.05
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.40
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
17.92
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.95
vs 25 benchmark
ROA
Return on assets percentage
-1.22
vs 25 benchmark
ROCE
Return on capital employed
-0.65
vs 25 benchmark
How AVCRF Stacks Against Its Sector Peers
| Metric | AVCRF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -4.02 | 28.45 | Better (Cheaper) |
| ROE | -95.30% | 763.00% | Weak |
| Net Margin | -84.76% | -45265.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 17.92 | 2795.60 | Strong Liquidity |
| ROA | -122.37% | -16588.00% (disorted) | Weak |
AVCRF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Avricore Health Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
6736.96%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
85.02%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
169.00%
Industry Style: Defensive, Growth, Innovation
High Growth